PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FBJ63
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $33,473
Award facts
- Contract value 100% obligated
- $33,472.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On November 26, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $33,472.70 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract, designated as delivery order 4570124067, is a firm fixed price, non-competitive set-aside award with performance completion targeted for November 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems worldwide.
AmerisourceBergen's federal contract portfolio demonstrates its critical role as a primary pharmaceutical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's delivery orders under the prime IDC reflect consistent firm fixed pricing across transactions ranging from under $100 to orders exceeding $45,000, showcasing its capability to fulfill diverse federal medical supply requirements including specialty medications, diabetes treatments, neurological therapies, and pain management pharmaceuticals. The Defense Logistics Agency is planning to establish successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen competitively among anticipated vendor selections for continued federal medical procurement support.
Quick answers
Who was awarded contract SPE2D826FBJ63?
SPE2D826FBJ63 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 26, 2025.
How much is contract SPE2D826FBJ63 worth?
The government has obligated $33,473 on SPE2D826FBJ63.
Is contract SPE2D826FBJ63 an order under another contract?
Yes. SPE2D826FBJ63 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FBJ63 competed?
The extent of competition for SPE2D826FBJ63 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award